Vivici is a Dutch company specializing in animal-free dairy ingredients. It was formed by DSM and Fonterra, two leaders in the global food and beverage space, and operates as a standalone company.
The company leverages precision fermentation technology and smart microorganisms to produce alternative protein ingredients, more specifically beta-lactoglobulin, a major whey protein in milk. The microorganisms are encoded with protein blueprints found in nature and are placed in fermentation vessels to create alternative proteins claimed to be identical to dairy proteins.
In October 2023 , the company announced it had scaled its production platform ahead of its slated flagship product launch. Vivici focuses on B2B customers and plans on supplying food and beverage producers seeking sustainable whey protein alternatives. In February 2024 , Vivici launched its whey protein alternative for commercial availability.
Key customers and partnerships
In November 2023 , the company partnered with Ginkgo Bioworks, a leading platform for cell programming and biosecurity, to optimize, develop, and commercialize functional alternative dairy proteins.
Funding and financials
In August 2023, the company raised an undisclosed amount in a seed funding round backed by DSM-Firmenich Venturing and Fonterra. The funding was earmarked for further product development and commercialization initiatives.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.